Valuation : Treace Medical Concepts, Inc.

Market Cap 295M 254M 239M 217M 407M 28.03B 409M 2.83B 1.09B 14.28B 1.11B 1.08B 45.24B P/E 2026 *
-5.33x
P/E 2027 * -5.85x
Enterprise Value 340M 293M 276M 251M 470M 32.38B 472M 3.27B 1.26B 16.5B 1.28B 1.25B 52.26B EV / Sales 2026 *
1.64x
EV / Sales 2027 * 1.72x
Free-Float
74.43%
Yield 2026 *
-
Yield 2027 * -
1 day-2.16%
1 week-3.62%
Current month-3.62%
1 month-4.83%
3 months+21.45%
6 months+174.55%
Current year+84.90%
1 week 4.5
Extreme 4.5
4.89
1 month 4.25
Extreme 4.25
5.01
Current year 1.17
Extreme 1.17
5.2
1 year 1.17
Extreme 1.17
7.61
3 years 1.17
Extreme 1.17
15.98
5 years 1.17
Extreme 1.17
31.02
10 years 1.17
Extreme 1.17
37.17
Manager TitleAgeSince
Chief Executive Officer 54 01/07/2013
Director of Finance/CFO 56 01/09/2020
Chief Tech/Sci/R&D Officer - 01/03/2022
Director TitleAgeSince
Chairman 54 20/05/2025
Director/Board Member 65 20/11/2020
Director/Board Member 68 20/11/2020
Date Insider Type Main position Quantity % Market Cap. Importance
24/08/26 Buy

Chief Executive Officer

11,000 0.0170%
09/08/26 Tax

Chief Financial Officer

-37,102 0.0572%
09/08/26 Tax

Responsable ventes & marketing

-9,814 0.0151%
Change 5-day change 1-year change 3-year change Capi.($)
-2.16%-3.62%-38.78%-66.64% 295M
+0.10%-1.00%+11.31%+9.08% 12.59B
-0.17%-2.42%+13.10%+25.85% 6.75B
-2.40%-4.21% - - 6.4B
-0.80%-10.34%+20.10%+7.58% 5.63B
-0.16%-2.44%-22.44%+40.54% 4.96B
+0.23%-0.96%-36.47%-21.47% 3.82B
-7.24%-12.34%+23.46%-21.97% 1.82B
+4.68%+4.21%-2.98%+140.86% 1.76B
-3.05%-1.94%+42.19%-19.41% 1.64B
Average -1.16%-3.50%+1.06%+10.49% 4.57B
Weighted average by Cap. -0.63%-3.15%+4.81%+15.48%

Financials

2026 *2027 *
Net sales 207M 179M 168M 153M 287M 19.74B 288M 1.99B 770M 10.06B 779M 762M 31.86B 222M 191M 180M 164M 306M 21.1B 308M 2.13B 823M 10.75B 833M 815M 34.05B
Net income -55.26M -47.56M -44.78M -40.8M -76.34M -5.26B -76.64M -531M -205M -2.68B -208M -203M -8.49B -51.01M -43.9M -41.33M -37.66M -70.46M -4.85B -70.74M -490M -189M -2.47B -192M -187M -7.83B
Net Debt 45.67M 39.3M 37M 33.71M 63.08M 4.35B 63.33M 439M 169M 2.21B 171M 168M 7.01B 86.44M 74.38M 70.04M 63.81M 119M 8.23B 120M 830M 321M 4.19B 325M 318M 13.28B
Logo Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Employees
450
Date Price Change Volume
09/09/26 $4.530 -2.16% 113,556
08/09/26 $4.630 -3.74% 267,917
04/09/26 $4.810 -1.43% 231,834
03/09/26 $4.880 +3.83% 275,358
02/09/26 $4.700 +2.17% 172,390
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
4.530USD
Average target price
5.500USD
Spread / Average Target
+21.41%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMCI Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!